Shares of Covalon Technologies Ltd. (OTCMKTS:CVALF - Get Free Report) rose 2.2% on Monday . The stock traded as high as $1.86 and last traded at $1.86. Approximately 2,000 shares were traded during trading, a decline of 88% from the average daily volume of 16,468 shares. The stock had previously closed at $1.82.
Covalon Technologies Stock Performance
The firm has a 50-day moving average of $1.69 and a 200-day moving average of $2.08. The firm has a market capitalization of $51.00 million, a P/E ratio of 26.58 and a beta of 0.49.
Covalon Technologies (OTCMKTS:CVALF - Get Free Report) last released its quarterly earnings data on Friday, February 21st. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.06. The business had revenue of $5.84 million during the quarter, compared to analysts' expectations of $6.37 million. Covalon Technologies had a return on equity of 12.33% and a net margin of 8.58%.
Covalon Technologies Company Profile
(
Get Free Report)
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Covalon Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Covalon Technologies wasn't on the list.
While Covalon Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
